Patient groups rebuke CVS on ICER, saying cost-effectiveness reviews discriminate
admin 14th September 2018 Uncategorised 0Patient groups are asking CVS to reconsider its move to allow clients to exclude drugs based on guidance from drug cost watchdog ICER, calling cost-effectiveness reviews discriminatory.
More: Patient groups rebuke CVS on ICER, saying cost-effectiveness reviews discriminate
Source: fierce